Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Phase II safety and efficacy study to evaluate a glaucoma therapy in open-angle glaucoma or ocular hypertension patients Clinical Trials Information presented on Clinical Trials Search isn't intended to be a substitute for proven healthcare advice, trips or treatment using a real physician. We are not docs. Always confer with your mD on Phase II safety and efficacy study to evaluate a glaucoma therapy in open-angle glaucoma or ocular hypertension patients conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Phase II safety and efficacy study to evaluate a glaucoma therapy in open-angle glaucoma or ocular hypertension patients Clinical research trials and Phase II safety and efficacy study to evaluate a glaucoma therapy in open-angle glaucoma or ocular hypertension patients medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectiveness of new drugs. The intention of the studies / projects is to resolve certain human health questions. Clinical trials are a popular means for physicians, government agencies, and private sector corporations to detect remedies for all forms of circumstances, like Phase II safety and efficacy study to evaluate a glaucoma therapy in open-angle glaucoma or ocular hypertension patients. Phase II safety and efficacy study to evaluate a glaucoma therapy in open-angle glaucoma or ocular hypertension patients Clinical Trials and other clinical trials allow for volunteers to undergo healthcare treatment options before they are available to the masses. Most times the participants receive treatment for free, and every now and again they are paid for their time. Occasionally there is a cost for a Phase II safety and efficacy study to evaluate a glaucoma therapy in open-angle glaucoma or ocular hypertension patients clinical trial. Subjects typically recieve the finest healthcare available for their Phase II safety and efficacy study to evaluate a glaucoma therapy in open-angle glaucoma or ocular hypertension patients condition. Hazards are a reality, nonetheless, and might include more or frequent mD trips, health risks (potentially life-endangering), and/or the treatment being ineffective. Trials are federally regulated with stern guidelines to protect clinical trials subjects.

Home > "P" Clinical Trials Conditions > Phase II safety and efficacy study to evaluate a glaucoma therapy in open-angle glaucoma or ocular hypertension patients

Phase II safety and efficacy study to evaluate a glaucoma therapy in open-angle glaucoma or ocular hypertension patients



Phase II safety and efficacy study to evaluate a glaucoma therapy in open-angle glaucoma or ocular hypertension patients

For Condition: Ocular Hypertension,Open-Angle Glaucoma
Status: No longer recruiting
Sponsor(s): Alcon Research ,
Synopsis: To determine the safety and IOP-lowering ability of a test compound in patients with open-angle glaucoma or ocular hypertension.
Details:
Eligibility:
Study Type:
  Interventional, Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Adult subjects of either sex and any race with open-angle glaucoma or ocular hypertension; - logMAR visual acuity not worse than 0.6. Exclusion Criteria: - Clinically relevant ophthalmic or systemic conditions may be excluded.
Total Enrollment: 

Location and Contact Information:

Alcon Clinical Trial Sites
Multiple Locations Throughout the US Sponsored by Alcon of,  Texas, 
United States
 


Additional Information:
Study ID Numbers:
  C-02-33;  C-02-33
Study Start Date: 
Record last reviewed: September 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00069719

Other Ocular Hypertension Studies:
1. Phase 3 study to evaluate IOP lowering therapy in open angle glaucoma and ocular hypertension C-02-41

2. A 6-week safety and efficacy study of Travatan compared to Xalcom in subjects with open-angle glaucoma(OAG) or ocular hypertension(OHT)

3. A 6-week safety & efficacy study of combination intraocular pressure-lowering therapy in patients with open-angle glaucoma or ocular hypertension

4. Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-forming Solution 0.25% and 0.5% in Pediatric Patients with Glaucoma or Ocular Hypertension.

5. Pigment Dispersion Syndrome With and Without Glaucoma

Related Studies:

Other Ocular Hypertension Clinical Trials
Other Texas Clinical Trials
Other Multiple Locations Throughout the US Sponsored by Alcon of Clinical Trials

Phase II safety and efficacy study to evaluate a glaucoma therapy in open-angle glaucoma or ocular hypertension patients

Modify your Search

  Other Ocular Hypertension Clinical Trials
  Other Texas Clinical Trials
  Other Multiple Locations Throughout the US Sponsored by Alcon of Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103